CB
57
3
MMC
70
2
LRCX
55
-6
NTAP
72
10
NWL
35
-4
SRE
61
14
SYF
83
2
CVS
43
2
K
42
-3
JCI
44
2
SBUX
36
4
NRG
72
-2
CHRW
56
2
HRB
85
-2
ZBH
48
-2
FLS
75
8
L
63
3
HOG
29
-10
FMC
31
-3
IP
62
-2
CB
57
3
MMC
70
2
LRCX
55
-6
NTAP
72
10
NWL
35
-4
SRE
61
14
SYF
83
2
CVS
43
2
K
42
-3
JCI
44
2
SBUX
36
4
NRG
72
-2
CHRW
56
2
HRB
85
-2
ZBH
48
-2
FLS
75
8
L
63
3
HOG
29
-10
FMC
31
-3
IP
62
-2
Financhill
Back

Intellia Therapeutics Stock Predictions

Sell
45

NTLA
Intellia Therapeutics

Last Price:
26.24
Seasonality Move:
33.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Intellia Therapeutics Stock Forecast

  • Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 39.7% based on the past 7 years of stock performance.
  • Intellia Therapeutics has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
  • Is Intellia Therapeutics Stock Undervalued?
    The current Intellia Therapeutics [NTLA] share price is $26.22. The Score for NTLA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Intellia Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Intellia Therapeutics has on average historically risen by 39.7% based on the past 7 years of stock performance.

Intellia Therapeutics Stock Rating

Sell
45
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics overpriced?

  • Intellia Therapeutics has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%

Intellia Therapeutics Stock Price History

Is NTLA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
intelliatx.com

52-Week Data

52-Week High:
47.48
52-Week Low:
19.37

Prediction Charts

Market Cap:
2.53B
Price in USD:
26.22
Volume:
1.09M
Beta:
2.03

Technical Analysis

SMA50:
24.93
SMA100:
26.50
SMA200:
29.22
52-Wk Change:
-40.14%

Stock Predictions

  • Is Intellia Therapeutics stock public?
    Yes, Intellia Therapeutics is a publicly traded company.
  • What is the Intellia Therapeutics stock quote today?
    The Intellia Therapeutics stock price is 26.22 USD today.
  • How to buy Intellia Therapeutics stock online?
    You can buy Intellia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-30 21.50 21.38 21.97 21.30
May-1 21.33 22.50 23.56 21.31
May-2 22.80 23.29 23.36 22.37
May-3 24.44 23.60 24.99 23.42
May-6 23.76 23.72 24.32 23.51
May-7 23.77 23.90 24.09 23.29
May-8 23.38 23.00 23.64 22.76
May-9 24.29 24.87 24.94 23.35
May-10 25.00 24.46 25.42 24.22
May-13 25.01 25.42 26.74 24.93
May-14 25.96 25.73 26.98 25.60
May-15 26.65 26.22 27.17 25.99
May-16 26.28 26.17 26.46 25.82
May-17 26.05 26.22 26.55 25.81

Intellia Therapeutics Earnings

Intellia Therapeutics Earnings Report: Per Share Intellia Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intellia Therapeutics Forecast Revenue Growth

Intellia Therapeutics Stock Analysis: Historical quarterly revenues per share for Intellia Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.26 per share, and a decrease next year of $0.19 per share.

* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.